Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or untreated. A machine learning model may help by analyzing routinely collected ...

Please provide your email address to receive an email when new articles are posted on . More than half of survey respondents being treated with monoclonal antibodies experienced a “wearing-off” effect ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

LOS ANGELES — People with multiple sclerosis (MS) who have greater difficulty multitasking are more likely to have more severe depression, according to findings that suggest interventions to treat ...

COPENHAGEN, Denmark — A higher cumulative genetic burden for depression is associated with an increased risk for relapse and worsening disability in people with multiple sclerosis (MS), early results ...

Multiple sclerosis (MS) has a nonspecific effect on psychiatric morbidity, increasing the risk of all psychiatric disorders, shows a large population-based study. “From a policy perspective, this ...

AUSTIN (KXAN)- Experts estimate that treatment-resistant depression (TRD) impacts about 2.8 million Americans annually, and a groundbreaking implantable device may offer new hope. Depression affects ...

Patients experience unpredictable symptoms including fatigue, pain, mobility issues, and cognitive changes. These symptoms shift and intensify over time, affecting daily life for both patients and ...